 TRILEPTAL
|
Novartis
|
| oxcarbazepina |
Anticonvulsivo |
| 300 mg comp.x 30 | $59.136,18 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $9.905,83 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $20.330,44 |
|
|
|
|
| 300 mg comp.x 60 | $98.485,40 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $17.720,58 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $30.899,45 |
|
|
|
|
| 600 mg comp.x 30 | $113.835,92 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $19.068,44 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $38.805,74 AF $75.030,18 |
|
|
|
|
| 600 mg comp.x 60 | $193.883,67 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $32.477,00 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $67.585,95 AF $126.297,72 |
|
|
|
|
| jbe.x 100 ml | $36.930,75 | (31/03/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $6.185,95 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $20.354,61 AF $16.576,14 |
|
|
|
|
| |
